Why is this controversial?
Ani-retroviral drugs to manage HIV have been sold by companies such as Abbott at high rates of $10,000 per patient, neither individuals nor governments can afford this cost as most of the world's HIV patients live in Sub-Saharan Africa.
Comments
No comments have yet been made